Therefore, we concluded that in spite of biopsy-induced hemorrhage, PSMA-PET/CT was capable of detecting primary tumor lesions in patients with high-risk PCa, regardless of the time interval between biopsy and PET. This evidence concerns the gene FOLH1 and neoplasm.